Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 3
1952 1
1953 4
1954 4
1955 4
1956 4
1957 1
1958 5
1959 5
1960 2
1961 3
1962 3
1963 7
1964 3
1965 2
1966 3
1967 2
1968 5
1969 8
1970 5
1971 2
1972 2
1973 2
1975 4
1976 2
1977 8
1978 3
1979 4
1980 3
1981 7
1982 2
1983 4
1984 6
1985 2
1986 11
1987 7
1988 7
1989 6
1990 6
1991 5
1992 6
1993 9
1994 9
1995 8
1996 9
1997 8
1998 9
1999 5
2000 11
2001 4
2002 9
2003 10
2004 6
2005 12
2006 10
2007 7
2008 7
2009 8
2010 8
2011 9
2012 6
2013 2
2014 5
2015 3
2016 5
2017 7
2018 10
2019 11
2020 12
2021 13
2022 7
2023 12
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

412 results

Results by year

Filters applied: . Clear all
Page 1
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Smith KL, Ferreiro T, Ribi K, Ruddy K, Kammler R, El-Abed S, Viale G, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O; International Breast Cancer Study Group; POSITIVE Trial Collaborators. Partridge AH, et al. Among authors: walshe jm. N Engl J Med. 2023 May 4;388(18):1645-1656. doi: 10.1056/NEJMoa2212856. N Engl J Med. 2023. PMID: 37133584 Free PMC article. Clinical Trial.
Palbociclib and Letrozole in Advanced Breast Cancer.
Finn RS, Martin M, Rugo HS, Jones S, Im SA, Gelmon K, Harbeck N, Lipatov ON, Walshe JM, Moulder S, Gauthier E, Lu DR, Randolph S, Diéras V, Slamon DJ. Finn RS, et al. Among authors: walshe jm. N Engl J Med. 2016 Nov 17;375(20):1925-1936. doi: 10.1056/NEJMoa1607303. N Engl J Med. 2016. PMID: 27959613 Free article. Clinical Trial.
Efficacy and safety of palbociclib in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2.
Gelmon K, Walshe JM, Mahtani R, Joy AA, Karuturi M, Neven P, Lu DR, Kim S, Schnell P, Bananis E, Schwartzberg L. Gelmon K, et al. Among authors: walshe jm. Breast. 2021 Oct;59:321-326. doi: 10.1016/j.breast.2021.07.017. Epub 2021 Jul 28. Breast. 2021. PMID: 34388698 Free PMC article. Clinical Trial.
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer.
Slamon DJ, Diéras V, Rugo HS, Harbeck N, Im SA, Gelmon KA, Lipatov ON, Walshe JM, Martin M, Chavez-MacGregor M, Bananis E, Gauthier E, Lu DR, Kim S, Finn RS. Slamon DJ, et al. Among authors: walshe jm. J Clin Oncol. 2024 Mar 20;42(9):994-1000. doi: 10.1200/JCO.23.00137. Epub 2024 Jan 22. J Clin Oncol. 2024. PMID: 38252901 Free PMC article. Clinical Trial.
Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial.
de Azambuja E, Agostinetto E, Procter M, Eiger D, Pondé N, Guillaume S, Parlier D, Lambertini M, Desmet A, Caballero C, Aguila C, Jerusalem G, Walshe JM, Frank E, Bines J, Loibl S, Piccart-Gebhart M, Ewer MS, Dent S, Plummer C, Suter T; APHINITY Steering Committee and Investigators. de Azambuja E, et al. Among authors: walshe jm. ESMO Open. 2023 Feb;8(1):100772. doi: 10.1016/j.esmoop.2022.100772. Epub 2023 Jan 19. ESMO Open. 2023. PMID: 36681013 Free PMC article. Clinical Trial.
The Kayser-Fleischer ring.
Walshe JM. Walshe JM. Br J Hosp Med (Lond). 2014 Mar;75(3):C38-9. doi: 10.12968/hmed.2014.75.sup3.c38. Br J Hosp Med (Lond). 2014. PMID: 24621667 No abstract available.
Systemic therapy for metastatic HER2-positive breast cancer.
Bredin P, Walshe JM, Denduluri N. Bredin P, et al. Among authors: walshe jm. Semin Oncol. 2020 Oct;47(5):259-269. doi: 10.1053/j.seminoncol.2020.07.008. Epub 2020 Aug 18. Semin Oncol. 2020. PMID: 32896428 Review.
Wilson's disease.
Walshe JM. Walshe JM. Lancet. 2007 Mar 17;369(9565):902. doi: 10.1016/S0140-6736(07)60438-3. Lancet. 2007. PMID: 17368141 No abstract available.
Wilson's disease.
Walshe JM. Walshe JM. Biochem J. 1969 Feb;111(3):8P-9P. doi: 10.1042/bj1110008p. Biochem J. 1969. PMID: 5767059 Free PMC article. No abstract available.
412 results